Explore

Reuters Reuters
US FDA blocked publication of COVID, shingles vaccine safety studies

US FDA blocked publication of COVID, shingles vaccine safety studies

By Padmanabhan Ananthan May 5 (Reuters) - Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the safety of widely used vaccines against COVID-19 and shingles, a Department of Health and Human Services spokesperson said.
Rapid Read Rapid Read
FDA Withdraws COVID and Shingles Vaccine Research Findings Over Data Concerns

FDA Withdraws COVID and Shingles Vaccine Research Findings Over Data Concerns

The Food and Drug Administration (FDA) has withdrawn the publication of studies that assessed the safety of COVID-19 and shingles vaccines. According to a spokesperson from the Department of Health and Human Services (HHS), the studies were retracted because the authors made broad conclusions that were not supported by the underlying data. This decision is part of the FDA's effort to maintain the integrity of its scientific process and ensure that all associated work meets high standards. The studies, which were funded by taxpayer money, analyzed millions of patient records and concluded that serious side effects from the vaccines were rare. However, the withdrawal has sparked concerns about the potential censorship of taxpayer-funded science and its impact on public health communication.
AP News AP News
FDA announces its first OK of fruit-flavored e-cigarettes for adults in major shift under Trump

FDA announces its first OK of fruit-flavored e-cigarettes for adults in major shift under Trump

U.S. health regulators have announced their first authorization of fruit-flavored electronic cigarettes intended for adult smokers
Rapid Read Rapid Read
State Legislatures Push for Raw Milk Legalization Amid Health Concerns

State Legislatures Push for Raw Milk Legalization Amid Health Concerns

A growing movement across the United States is advocating for the legalization and increased availability of raw milk, despite significant health warnings from public health officials. More than three dozen bills supporting raw milk have been introduced in state legislatures, with a bipartisan bill in the U.S. House aiming to prevent federal restrictions on interstate raw milk sales. Proponents argue for consumer choice and compare raw milk to other regulated products like alcohol and tobacco. However, public health experts warn of the risks associated with raw milk, which can harbor harmful bacteria such as E. coli, salmonella, and listeria. The Centers for Disease Control and Prevention (CDC) has documented over 200 outbreaks linked to raw milk from 1998 to 2018, resulting in numerous illnesses and hospitalizations.
AP News AP News
What to know about hantavirus, the illness linked to a cruise ship outbreak

What to know about hantavirus, the illness linked to a cruise ship outbreak

A suspected outbreak aboard a cruise ship of a rare, a rodent-borne illness called hantavirus has left three people dead and sickened others
Rapid Read Rapid Read
FDA Issues Recall for a2 Milk Baby Formula Due to Toxin Concerns

FDA Issues Recall for a2 Milk Baby Formula Due to Toxin Concerns

The Food and Drug Administration (FDA) has announced a voluntary recall of three batches of a2 Platinum Premium USA 0-12 months baby formula by the a2 Milk Company. The recall was initiated after the detection of cereulide, a toxin produced by Bacillus cereus, during product testing. This toxin can cause food poisoning, leading to symptoms such as diarrhea, vomiting, and stomach pains. The affected batches, totaling 63,078 units, were distributed nationally through the company's website, Amazon, and Meijer stores. The formula, designed for infants up to 12 months old, was sold in 31.7oz tins with use-by dates extending into 2027. The FDA advises consumers to discard the formula or return it for a refund, and to seek medical attention if concerned about their child's health.
Rapid Read Rapid Read
Visa Delays Threaten Healthcare in Underserved U.S. Areas

Visa Delays Threaten Healthcare in Underserved U.S. Areas

The Department of Health and Human Services' visa waiver program, which allows foreign doctors to work in underserved U.S. areas, is experiencing significant delays. Hundreds of physicians awaiting J-1 visa waivers may have to leave the country if their applications are not processed by July 30. This backlog is causing concern among healthcare providers, as these doctors are crucial for serving vulnerable populations. The delays coincide with a new $100,000 fee for H-1B visas, which many hospitals cannot afford, further complicating the situation.
Trendline Trendline
A2 Milk Recalls Infant Formula in U.S. Due to Toxin Concerns

A2 Milk Recalls Infant Formula in U.S. Due to Toxin Concerns

A2 Milk Recalls Infant Formula in U.S. Due to Toxin Concerns
AP News AP News
What to know about hantavirus, the illness suspected in a cruise ship outbreak

What to know about hantavirus, the illness suspected in a cruise ship outbreak

Three people have died and others have been sickened by what health authorities suspect is a hantavirus outbreak on a cruise ship in the Atlantic Ocean
Rapid Read Rapid Read
FDA Warns of Undeclared Nuts in Keto Crunch Smart Mix, Potential Allergy Risk

FDA Warns of Undeclared Nuts in Keto Crunch Smart Mix, Potential Allergy Risk

The U.S. Food and Drug Administration (FDA) has issued a warning regarding the presence of undeclared cashews, pistachios, and cherries in Second Nature Brands' Keto Crunch Smart Mix. This recall affects 10-ounce packages distributed nationwide, posing a risk to consumers with nut allergies. The issue arose from a labeling error, and while no illnesses have been reported, the recall is a precautionary measure. Consumers are advised not to consume the affected product and to contact the company for a refund.
Rapid Read Rapid Read
Legal Challenge to CMS Hemp Strategy Raises Concerns Over FDA Authority

Legal Challenge to CMS Hemp Strategy Raises Concerns Over FDA Authority

A federal lawsuit in the U.S. District Court for the District of Columbia is challenging the legality of the Centers for Medicare & Medicaid Services' (CMS) Beneficiary Engagement Incentive (BEI) model. This program allows the furnishing of certain hemp-derived cannabinoid products to Medicare beneficiaries without U.S. Food and Drug Administration (FDA) approval. The case, Smart Approaches to Marijuana (SAM) et al. v. Robert F. Kennedy Jr. et al., questions whether CMS can introduce cannabinoid products into Medicare-connected environments without the traditional FDA approval process. Critics argue that this policy shift undermines the established sequence of science, clinical trials, FDA approval, and coverage integration, potentially signaling that clinical evidence is optional.
Reuters Reuters
NZ's a2 Milk shares slump on US infant formula recall as cereulide detected

NZ's a2 Milk shares slump on US infant formula recall as cereulide detected

May 4 (Reuters) - New Zealand's a2 Milk said on Monday it was recalling three batches of its a2 Platinum infant milk formula sold in the United States after testing detected cereulide, sending its shares down nearly 14%.